The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $139.03

Today's change0.00 0.00%
Updated September 2 4:01 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $139.03

Today's change0.00 0.00%
Updated September 2 4:01 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp closed at (U.S.)$139.03.

Shares have lost 0.80% over the last five days, but have gained 9.15% over the last year to date. This security has outperformed the S&P 500 by 45.15% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $139.03
  • High--
  • Low--
  • Bid / Ask(U.S.) $132.50 / (U.S.) $143.48
  • YTD % change+9.15%
  • Volume0
  • Average volume (10-day)1,411,473
  • Average volume (1-month)1,133,208
  • Average volume (3-month)1,108,955
  • 52-week range(U.S.) $96.84 to (U.S.) $159.00
  • Beta0.70
  • Trailing P/E34.66×
  • P/E 1 year forward31.83×
  • Forward PEG2.31×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.01
Updated September 2 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.08%

Based on its net profit margin of 18.08%, Edwards Lifesciences Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue617590618607
Total other revenue--------
Total revenue617590618607
Gross profit458454458439
Total cost of revenue159136160168
Total operating expense475428485487
Selling / general / administrative214203223222
Research & development98868488
Depreciation / amortization--------
Interest expense (income), net operating4444
Unusual expense (income)10114
Other operating expenses, total0001
Operating income142163133121
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax142163133121
Income after tax11312310995
Income tax, total30392426
Net income11312310995
Total adjustments to net income--------
Net income before extra. items11312310995
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items11312310995
Inc. avail. to common incl. extra. items11312310995
Diluted net income11312310995
Dilution adjustment0----0
Diluted weighted average shares110110110108
Diluted EPS excluding extraordinary itemsvalue per share1.021.121.000.87
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.031.121.080.90